Multiple myeloma cells express key immunoregulatory cytokines and modulate the monocyte migratory response
- Leonardo Freire-de-Lima,
- Ana Flávia Fernandes Ribas Nardy,
- ,
- Luciana Conde,
- Jéssica Santos Lemos,
- Leonardo Marques da Fonseca
- Universidade Federal do Rio de Janeiro,
- University of the Pacific,
- Fundação Oswaldo Cruz
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Abstract
<p>Multiple myeloma (MM) is a plasma cell disorder that still remains incurable. The immune dysfunction of the host is a striking characteristic of MM, leading to tumor growth and reducing the survival rate of patients. Monocytes are precursors of conventional dendritic cells (DCs), a major player in the immunity mechanisms driving protective T cell responses against tumor. Herein, we report that human MM RPMI 8226 cell line shows a pronounced chemoattractant activity for monocytes and also expresses enhanced levels of the leukocyte chemotactic cytokines CXCL12, CCL5, MIP-1β, and CXCL10 in association with elevated levels of both key immunoregulatory interleukins such as IL-4 and IL-10. This cytokine profile was observed together with reduced expression of IFN-ϒ by MM RPMI 8226 cell line, a determinant interleukin involved in the acquisition of cellular-mediated protective responses against tumor cells. We further demonstrate that MM RPMI 8226 cell line expresses elevated levels of soluble form of the intercellular adhesion molecule-1 known to inhibit antitumoral T cell responses. This attractive modulation of immune responses by MM cells might provide a means to impair early antitumor responses during the establishment of cytokine-mediated immunosuppressive tumor niche.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Article number
92Journal (Volume, Issue Number)
Frontiers of Medicine (Volume 4)Publication milestones
- Published - 06/27/2017
Publication status
Published - 06/27/2017
ISSN
2095-0217Publication IDs
- Scopus: 85037983360
Publication metrics
Metrics
SciVal
FWCI
0.46
SciVal
Author count
9
SciVal
Paper percentile
51
SciVal
citations
3
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
27
Citation count
13
Funding Details
This work was supported by grants from Fundação do Câncer, Conselho Nacional de Desenvolvimento Científico e Tecnológico do Brasil (CNPq), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ).
